Abdominal Pain News and Research

RSS

Abdominal pain is traditionally described by its chronicity (acute or chronic), its progression over time, its nature (sharp, dull, colicky), its distribution (by various methods, such as abdominal quadrant (left upper quadrant, left lower quadrant, right upper quadrant, right lower quadrant) or other methods that divide the abdomen into nine sections), and by characterization of the factors that make it worse, or alleviate it.

Specific bacterium in the gut associated with IBS symptoms

Researchers at the University of Gothenburg have detected a connection between Brachyspira, a genus of bacteria in the intestines, and IBS -- especially the form that causes diarrhea.

25 Nov 2020

A review of Traditional Chinese herbal medicine in management of COVID-19

Now researcher have summarized the experiences with the use of traditional Chinese herbal medicines for the management of COVID-19. Their study titled, “Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis,” was published in the January 2021 issue of the journal Phytomedicine.

24 Nov 2020

COVID-19 lockdown is associated with high blood pressure

Lockdown due to the COVID-19 pandemic is associated with an increase in high blood pressure among patients admitted to emergency.

19 Nov 2020

Teenagers facing COVID-19 and EVALI show similar symptoms

A UC Davis Health pediatric team presented a powerful case series of three teenagers who had unexplained breathing problems during the COVID-19 pandemic.

19 Nov 2020

Examining potential foodborne transmission of SARS-CoV-2 through fresh produce

To address this gap in knowledge, researchers from the Bureau of Microbial Hazards, Health Canada, and Faculty of Medicine, University of Ottawa examined the survival of human coronaviruses on the surface of fresh produce such as apples, cucumbers, and tomatoes.

18 Nov 2020

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Scientists in Taiwan recently published a report on their use of anti-neutrophil strategies to treat acute respiratory distress syndrome (ARDS) – a life-threatening condition that can arise in critical COVID-19 cases – in the journal Frontiers in Pediatrics.

15 Nov 2020

Research shows a unique T cell receptor repertoire in MIS-C patients

Children with coronavirus disease 2019 (COVID-19) sometimes develop the Multisystem Inflammatory Syndrome in Children (MIS-C), which is associated with high morbidity. The underlying T-cell associated mechanism is described by researchers in a new study published on the preprint server bioRxiv in November 2020, as a response to superantigen activation.

11 Nov 2020

Review: One in five COVID-19 patients may only show gastrointestinal symptoms

Almost one in five patients with COVID-19 may only show gastrointestinal symptoms, according to a review of academic studies published in the journal Abdominal Radiology. The findings of the review suggest abdominal radiologists need to remain vigilant during the pandemic while imaging patients.

3 Nov 2020

High-sugar diet can damage the gut’s protective mucus layer, lead to worse colitis

Mice fed diets high in sugar developed worse colitis, a type of inflammatory bowel disease (IBD), and researchers examining their large intestines found more of the bacteria that can damage the gut's protective mucus layer.

28 Oct 2020

People with depression are more likely to develop Crohn's disease

A new study, published inGut, has found depression is more common among people with Crohn's disease or ulcerative colitis in the years before they are diagnosed with these bowel conditions.

28 Oct 2020

Delaying urgent health issues can be more harmful than the potential risk of COVID-19

More than half a year into the COVID-19 (coronavirus) pandemic, healthcare providers have adapted by offering virtual visits and observing strict safety measures in clinics.

27 Oct 2020

Intestinal microbiota offers new prospects for treating celiac disease

Celiac disease is an immune disease of the intestine that affects more than 1% of the population. It is characterised by gluten intolerance that causes inflammation of the gut, abdominal pain and diarrhoea, and can lead to weight loss and deficiencies among patients.

23 Oct 2020

New model could help identify people at risk for long COVID

Researchers in the UK, United States, and Sweden have presented new findings that could help identify individuals at risk of "long COVID" – a protracted course of coronavirus disease 2019 (COVID-19) symptoms last for more than 28 days.

22 Oct 2020

Gene variants may provide clues to successful treatment of pediatric eosinophilic esophagitis

A group of three gene variants, commonly inherited together, may provide clues to more successful treatment of pediatric eosinophilic esophagitis (EoE), a chronic inflammation of the food pipe often confused with gastroesophageal reflux disease (GERD).

16 Oct 2020

Pregnant and postpartum women more likely to suffer from constipation

Women are 2–3 times more likely to suffer from constipation during pregnancy and right after childbirth than at any other time in their life, a new study from the University of Eastern Finland shows.

9 Oct 2020

Wearable device tracks biomarkers in sweat associated with inflammatory bowel disease

University of Texas at Dallas researchers have designed a wearable device that monitors sweat for biomarkers that could signal flare-ups of inflammatory bowel disease (IBD).

28 Sep 2020

FDA approves first drug for patients with hypereosinophilic syndrome in nearly 14 years

Today, the U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

25 Sep 2020